- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cellbion Co Ltd (308430)
Cellbion Co Ltd stock price live, this page displays KQ 308430 stock exchange data. View the 308430 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cellbion Co Ltd real time stock price chart below.
What Is the Cellbion Co Ltd Stock Price Today?
The Cellbion Co Ltd stock price today is 17,370.00.
What Is the Stock Symbol for Cellbion Co Ltd?
The stock symbol for Cellbion Co Ltd is ""308430.""
What Stock Exchange Does Cellbion Co Ltd Trade On?
Cellbion Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is Cellbion Co Ltd a Good Stock to Buy?
Determining whether Cellbion Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 308430 quote. (ISIN: KR7308430008)
What Is the Cellbion Co Ltd Stock Price Today?
The Cellbion Co Ltd stock price today is 17,370.00.
What Is the Stock Symbol for Cellbion Co Ltd?
The stock symbol for Cellbion Co Ltd is ""308430.""
What Stock Exchange Does Cellbion Co Ltd Trade On?
Cellbion Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is Cellbion Co Ltd a Good Stock to Buy?
Determining whether Cellbion Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 308430 quote. (ISIN: KR7308430008)
KOSDAQ
Currency in KRW
17,370.00
-400.00(-2.25%)
Closed·
Fair Value
An estimate of a Cellbion's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16,890.00
17,780.00
52 wk Range
9,930.00
29,600.00
308430 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
308430 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Cellbion's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16,890.0017,780.00
52 wk Range
9,930.0029,600.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
308430 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Cellbion's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Cellbion Co Ltd Company Profile
CellBion Co., Ltd. engages in the research and development of radiopharmaceutical products. Its clinical stage pipeline includes 177Lu-PSMA-DGUL, indicated for prostate cancer radiotherapy, currently under Phase 2 clinical stage; 225Ac-Antibody, indicated for multiple cancer types, currently under pre-clinical stage; 225Ac-DGUL, indicated for prostate cancer radiotherapy, currently under pre-clinical stage; 68Ga-Nota-MSA, indicated for cardiovascular disease diagnosis, currently under Phase 2 clinical stage; 99mTc-MSA-ICG, indicated for lymphoscintigraphy SLN mapping, currently under Phase 1 clinical stage; and 68Ga-NGUL, indicated for prostate cancer diagnosis, currently under Phase 2 clinical stage. It is also involved in the development of preclinical stage pipeline comprising 68 Ga-FAP, indicated for solid tumors diagnosis; 225 Ac-FAP, indicated for solid tumors radiotherapy; and peptide-based radioligand therapy and antibody-radionuclide conjugates for undisclosed indications. The company was founded in 2010 and is headquartered in Seoul, South Korea.
Compare 308430 to Peers and Sector
Metrics to compare | 308430 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship308430PeersSector | |
|---|---|---|---|---|
P/E Ratio | −30.0x | −0.8x | −0.7x | |
PEG Ratio | 1.32 | 0.04 | 0.00 | |
Price/Book | 8.4x | 4.1x | 2.6x | |
Price / LTM Sales | 84.7x | 3.2x | 3.4x | |
Upside (Analyst Target) | - | 22.4% | 38.0% | |
Fair Value Upside | Unlock | 7.9% | 5.3% | Unlock |
Earnings
Latest Release
Jul 30, 2025
EPS / Forecast
-195.00 / --
Revenue / Forecast
404.46M / --
People Also Watch
FAQ
What Stock Exchange Does Cellbion Trade On?
Cellbion is listed and trades on the KOSDAQ stock exchange.
What Is the Stock Symbol for Cellbion?
The stock symbol for Cellbion is "308430."
What Is the Cellbion Market Cap?
As of today, Cellbion market cap is 222.66B.
What Is Cellbion's Earnings Per Share (TTM)?
The Cellbion EPS (TTM) is -665.27.
From a Technical Analysis Perspective, Is 308430 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Cellbion Stock Split?
Cellbion has split 0 times.
How Many Employees Does Cellbion Have?
Cellbion has 0 employees.
What is the current trading status of Cellbion (308430)?
As of 11 Oct 2025, Cellbion (308430) is trading at a price of 17,370.00, with a previous close of 17,590.00. The stock has fluctuated within a day range of 16,890.00 to 17,780.00, while its 52-week range spans from 9,930.00 to 29,600.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.